ATRS insider transactions
Antares Pharma Inc. (ATRS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ATRS
- SEC Form 4: Roche Robert P Jr returned $939,775 worth of shares to the company (167,817 units at $5.60), closing all direct ownership in the company4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Gueth Anton returned $2,618,431 worth of shares to the company (467,577 units at $5.60), closing all direct ownership in the company4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Richardson Peter C returned $283,433 worth of shares to the company (50,613 units at $5.60), closing all direct ownership in the company4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Smith Karen L. returned $446,012 worth of shares to the company (79,645 units at $5.60), closing all direct ownership in the company4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Jacob Leonard S returned $955,220 worth of shares to the company (170,575 units at $5.60), closing all direct ownership in the company4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Graham Peter J returned $4,148,721 worth of shares to the company (740,843 units at $5.60), closing all direct ownership in the company4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Garrity Thomas J returned $1,399,205 worth of shares to the company (249,858 units at $5.60), closing all direct ownership in the company4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Powell Fred M returned $5,125,512 worth of shares to the company (915,270 units at $5.60), closing all direct ownership in the company4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Apple Robert F returned $16,029,770 worth of shares to the company (2,862,459 units at $5.60), closing all direct ownership in the company4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4 filed by Volkart Carmen B4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Greenleaf Peter returned $446,012 worth of shares to the company (79,645 units at $5.60), closing all direct ownership in the company4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Apple Robert F was granted 86,814 shares and covered exercise/tax liability with 37,695 shares, increasing direct ownership by 2% to 2,488,360 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Powell Fred M was granted 27,780 shares and covered exercise/tax liability with 11,506 shares, increasing direct ownership by 2% to 791,036 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Graham Peter J was granted 26,044 shares and covered exercise/tax liability with 13,635 shares, increasing direct ownership by 2% to 616,609 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Graham Peter J was granted 23,068 shares and covered exercise/tax liability with 13,299 shares, increasing direct ownership by 2% to 604,200 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Powell Fred M was granted 24,606 shares and covered exercise/tax liability with 11,496 shares, increasing direct ownership by 2% to 774,762 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Apple Robert F was granted 76,893 shares and covered exercise/tax liability with 34,282 shares, increasing direct ownership by 2% to 2,439,241 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 5: Jacob Leonard S gifted 125,000 shares, decreasing direct ownership by 42% to 170,575 units5 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4 filed by Volkart Carmen B4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 3 filed by new insider Volkart Carmen B3 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Jacob Leonard S was granted 24,679 units of Common Stock and covered exercise/tax liability with 13,820 units of Common Stock, increasing direct ownership by 4% to 295,575 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4 filed by Antares Pharma, Inc.4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Smith Karen L. was granted 25,452 units of Common Stock, increasing direct ownership by 47% to 79,645 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: ROCHE ROBERT P JR was granted 25,452 units of Common Stock, increasing direct ownership by 18% to 167,817 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Richardson Peter C was granted 36,199 units of Common Stock4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Powell Fred M covered exercise/tax liability with 29,207 units of Common Stock and was granted 85,973 units of Common Stock, increasing direct ownership by 8% to 761,652 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: JACOB LEONARD S was granted 31,674 units of Common Stock, increasing direct ownership by 13% to 284,716 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: GUETH ANTON was granted 25,452 units of Common Stock, increasing direct ownership by 5% to 567,577 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Greenleaf Peter was granted 25,452 units of Common Stock, increasing direct ownership by 47% to 79,645 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: GRAHAM PETER J was granted 85,973 units of Common Stock and covered exercise/tax liability with 37,800 units of Common Stock, increasing direct ownership by 9% to 594,431 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: GARRITY THOMAS J was granted 25,452 units of Common Stock, increasing direct ownership by 11% to 249,858 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: APPLE ROBERT F was granted 248,869 units of Common Stock and covered exercise/tax liability with 99,209 units of Common Stock, increasing direct ownership by 7% to 2,396,630 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: Powell Fred M covered exercise/tax liability with 12,045 units of Common Stock, decreasing direct ownership by 2% to 704,886 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: GRAHAM PETER J covered exercise/tax liability with 15,996 units of Common Stock, decreasing direct ownership by 3% to 546,258 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: APPLE ROBERT F covered exercise/tax liability with 44,223 units of Common Stock, decreasing direct ownership by 2% to 2,246,970 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: GUETH ANTON exercised 40,000 units of Common Stock at a strike of $1.66, increasing direct ownership by 8% to 542,125 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: GUETH ANTON exercised 72,669 units of Common Stock at a strike of $1.66, increasing direct ownership by 17% to 502,125 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4 filed by Richardson Peter C4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 3 filed by Richardson Peter C3 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: J Thomas Garrity sold $214,000 worth of Common Stock (50,000 units at $4.28) and exercised 50,000 units of Common Stock at a strike of $1.124 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: M Fred Powell was granted 45,829 units of Common Stock and disposed of $89,546 worth of Common Stock (19,899 units at $4.50), increasing ownership by 4% to 716,931 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: J Peter Graham disposed of $107,964 worth of Common Stock (23,992 units at $4.50) and was granted 45,829 units of Common Stock, increasing ownership by 4% to 562,254 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: F Robert Apple was granted 152,763 units of Common Stock and disposed of $298,485 worth of Common Stock (66,330 units at $4.50), increasing ownership by 4% to 2,291,193 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: M Fred Powell was granted 80,365 units of Common Stock and disposed of $169,471 worth of Common Stock (35,829 units at $4.73), increasing ownership by 7% to 691,001 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: F Robert Apple was granted 267,878 units of Common Stock, disposed of $550,160 worth of Common Stock (116,313 units at $4.73), exercised 255,519 units of Common Stock at a strike of $0.92 and sold $2,486,194 worth of Common Stock (497,479 units at $5.00), decreasing ownership by 4% to 2,204,760 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: S Leonard Jacob exercised 15,321 units of Common Stock at a strike of $2.24 and sold $77,371 worth of Common Stock (15,321 units at $5.05)4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: J Peter Graham exercised 45,000 units of Common Stock at a strike of $1.12, sold $221,650 worth of Common Stock (45,000 units at $4.93), was granted 80,365 units of Common Stock and disposed of $199,005 worth of Common Stock (42,073 units at $4.73), increasing ownership by 8% to 540,417 units4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: J Thomas Garrity exercised 50,000 units of Common Stock at a strike of $1.12 and sold $231,000 worth of Common Stock (50,000 units at $4.62)4 - ANTARES PHARMA, INC. (0001016169) (Issuer)
- SEC Form 4: F Robert Apple exercised 89,981 units of Common Stock at a strike of $2.62 and sold $427,410 worth of Common Stock (89,981 units at $4.75)4 - ANTARES PHARMA, INC. (0001016169) (Issuer)